Clinical Trials

NCT03257761 | ACTIVE_NOT_RECRUITING | PHASE1
55 participants

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2018-02-07
Completion:
2021-09-27
Conditions
  • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
  • Gallbladder Adenocarcinoma, Biliary Type
  • Metastatic Pancreatic Adenocarcinoma
  • Recurrent Cholangiocarcinoma
  • Recurrent Gallbladder Carcinoma
  • Recurrent Hepatocellular Carcinoma
  • Recurrent Intrahepatic Cholangiocarcinoma
  • Recurrent Pancreatic Carcinoma
  • Stage III Gallbladder Cancer AJCC V7
  • Stage III Hepatocellular Carcinoma AJCC v7
  • Stage III Intrahepatic Cholangiocarcinoma AJCC v7
  • Stage III Pancreatic Cancer AJCC v6 and v7
  • Stage IIIA Gallbladder Cancer AJCC v7
  • Stage IIIA Hepatocellular Carcinoma AJCC v7
  • Stage IIIB Gallbladder Cancer AJCC v7
  • Stage IIIB Hepatocellular Carcinoma AJCC v7
  • Stage IIIC Hepatocellular Carcinoma AJCC v7
  • Stage IV Gallbladder Cancer AJCC v7
  • Stage IV Hepatocellular Carcinoma AJCC v7
  • Stage IV Pancreatic Cancer AJCC v6 and v7
  • Stage IVA Gallbladder Cancer AJCC v7
  • Stage IVA Hepatocellular Carcinoma AJCC v7
  • Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7
  • Stage IVB Gallbladder Cancer AJCC v7
  • Stage IVB Hepatocellular Carcinoma AJCC v7
  • Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7
  • Unresectable Gallbladder Carcinoma
  • Unresectable Pancreatic Carcinoma
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT03213002 | RECRUITING | PHASE1/PHASE2
67 participants

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2017-06-13
Completion:
2028-06-30
Conditions
  • Glioblastoma Multiforme (GBM)
  • Glioblastoma
  • Glioma of Brain
  • Glioblastoma, Adult
  • Brain Tumor
  • Brain Tumor, Primary
  • Brain Tumor Adult
  • Cancer
  • Brain Cancer
Interventions
  • DRUG
No Results Yet
NCT03148743 | RECRUITING
50 participants

FMT in Gut aGVHD Treated

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-01
Start Date:
2017-05-16
Completion:
2028-12-01
Conditions
  • Acute-graft-versus-host Disease
Interventions
  • BIOLOGICAL
No Results Yet
NCT02220985 | COMPLETED | PHASE2
84 participants

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2015-03-23
Completion:
2025-04-01
Conditions
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Acute Biphenotypic Leukemia
  • Acute Leukemia of Ambiguous Lineage
  • Acute Undifferentiated Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplant Recipient
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Childhood Acute Lymphoblastic Leukemia in Remission
  • Childhood Acute Myeloid Leukemia in Remission
  • Donor
  • Lymphoblastic Lymphoma
  • Myelodysplastic Syndrome With Excess Blasts
  • Myelodysplastic Syndrome With Excess Blasts-1
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood Acute Myeloid Leukemia
  • Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia in Remission
  • Acute Myeloid Leukemia in Remission
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • RADIATION
Previous
Sorted by latest updates
Next
Showing 40 trials per page